| Literature DB >> 25583767 |
Douglas E Wood1, Ella Kazerooni1, Scott L Baum1, Mark T Dransfield1, George A Eapen1, David S Ettinger1, Lifang Hou1, David M Jackman1, Donald Klippenstein1, Rohit Kumar1, Rudy P Lackner1, Lorriana E Leard1, Ann N C Leung1, Samir S Makani1, Pierre P Massion1, Bryan F Meyers1, Gregory A Otterson1, Kimberly Peairs1, Sudhakar Pipavath1, Christie Pratt-Pozo1, Chakravarthy Reddy1, Mary E Reid1, Arnold J Rotter1, Peter B Sachs1, Matthew B Schabath1, Lecia V Sequist1, Betty C Tong1, William D Travis1, Stephen C Yang1, Kristina M Gregory1, Miranda Hughes1.
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening provide recommendations for selecting individuals for lung cancer screening, and for evaluation and follow-up of nodules found during screening, and are intended to assist with clinical and shared decision-making. These NCCN Guidelines Insights focus on the major updates to the 2015 NCCN Guidelines for Lung Cancer Screening, which include a revision to the recommendation from category 2B to 2A for one of the high-risk groups eligible for lung cancer screening. For low-dose CT of the lung, the recommended slice width was revised in the table on "Low-Dose Computed Tomography Acquisition, Storage, Interpretation, and Nodule Reporting."Entities:
Mesh：
Year: 2015 PMID： 25583767 DOI： 10.6004/jnccn.2015.0006
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908